Clinical Trials Browser

Phase 1/2 × COVID-19 × Practice Guidelines as Topic × Clear all

NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Phase 1/2 Active not recruiting

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms